CME
Podcast
Thanks for your interest in this podcast. Please read this important program information before listening.
Episode Description
This PER® Spectives™ featured podcast brings together 3 leading experts to discuss the evolving role of PSMA in prostate cancer management. The conversation focuses on precision medicine approaches that leverage PSMA-PET imaging and radioligand therapy to optimize patient care. Key topics include advancements in PSMA-targeted radiotracers, patient selection for PSMA-directed therapies, and overcoming barriers to clinical implementation. This program is designed to equip clinicians with the knowledge to integrate PSMA-based strategies into practice, improving outcomes for patients with prostate cancer.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Novartis.
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.
Instructions on How to Receive Credit
Today’s faculty are:
Mary-Ellen Taplin, MD
Chair, Executive Committee for Clinical Research
Director of Clinical Research
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Jason A. Efstathiou, MD, DPhil, FASTRO, FACRO
Professor of Radiation Oncology
Harvard Medical School
Vice Chair, Faculty & Academic Affairs
Director, Genitourinary Division
Department of Radiation Oncology
Co-Director, Bertucci Center for Genitourinary Cancers
Mass General Cancer Center
Massachusetts General Hospital
Boston, MA
Phillip J. Koo, MD
Division Chief of Diagnostic Imaging
Physician Executive of Oncology
Banner MD Anderson Cancer Center
Phoenix, AZ
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Release Date
January 16, 2025
Expiration Date
January 16, 2026